<DOC>
	<DOCNO>NCT02185014</DOCNO>
	<brief_summary>This study evaluate long term efficacy , safety , tolerability repeat administration adalimumab subject Crohn 's disease .</brief_summary>
	<brief_title>Open Label Study Evaluate Long Term Efficacy , Safety Tolerability Repeated Dosing Subjects With Crohn 's Disease Who Participated Successfully Completed M14-115</brief_title>
	<detailed_description />
	<mesh_term>Crohn Disease</mesh_term>
	<mesh_term>Adalimumab</mesh_term>
	<criteria>Subject successfully enrol complete Study M14115 , include Week 12 ileocolonoscopy . If Week 12 ( Study M14115 ) colonoscopy show evidence dysplasia malignancy . Subject compliance prior concomitant medication requirement throughout M14115 . Subject develop active Tuberculosis ( TB ) M14115 , subject non compliant prophylaxis latent TB initiate per M14115 procedure .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Crohn 's Disease</keyword>
</DOC>